At A CAGR Of 35.42% , Global Alpha-1 Antitrypsin Drugs Industry will rise in the period of 2016-2020
ResearchMoz presents this most up-to-date research on Global Alpha-1 Antitrypsin Drugs Market 2016-2020. About Alpha-1 antitrypsin Drugs Alpha-1 antitrypsin, also known as an alpha-1 protease inhibitor (A1PI), is a glycoprotein produced in the liver that helps in the inactivation of enzymes such as elastase, which break down proteins during inflammation induced by some injury. The decline in alpha-1 antitrypsin levels in the blood results in a rare genetic condition known as alpha-1 antitrypsin deficiency (AATD), which leads to the development of respiratory and liver diseases, and severe skin infections. The disease is passed on from parents to an offspring through mutated genes. Augmentation therapy using drugs derived from human plasma helps in maintaining levels of alpha-1 antitrypsin in the blood, helping in remission of the condition. Technavios analysts forecast the global alpha-1 antitrypsin drugs market to grow at a CAGR of 35.42% during the period 2016-2020. Covered : The r...